In a clinical trial, social functioning was improved by the use of intranasal oxytocin (Hall et al., 2012) and symptoms of ADHD were improved with the use of pharmaceutical stimulants, such as methylphenidate (Hagerman et al., 1988). Here, OXT is linked to attention deficit-hyperactivity disorder.